Clinical Trial

Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP

Study acronym: LIDO ERCP
Completed Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy of intravenous lidocaine infusion on duodenal peristalsis during Endoscopic Retrograde Cholangiopancreatography (ERCP). The study compares lidocaine against a placebo to determine if lidocaine can reduce the need for rescue spasmolytics (hyoscine-N-butylbromide or glucagon), decrease propofol consumption, and improve hemodynamic stability.
Protocol Amendment History 1 change
critical Trial completed 2026-04-09
Trial Details
NCT Number NCT07333859
Lead Sponsor Ankara City Hospital Bilkent
Conditions Duodenal Spasm, ERCP, Sedation
Enrollment 120 participants
Start Date 2026-02-11
Primary Completion 2026-02-11 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-08